Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.54558 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.5049 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.50778 | 22 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.44815 | 21 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.44939 | 21 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.62039 | 24 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.53447 | 21 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.47996 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.46666 | 21 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.49333 | 21 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.48717 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.47245 | 21 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.49788 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49653 | 21 |